Zobrazeno 1 - 8
of 8
pro vyhledávání: '"I Plo Seco"'
Autor:
S Álvarez Atienza, P Martinez De La Cruz, I Plo Seco, L Moreno Nuñez, S Sanz Márquez, JF Valverde Canovas, M Perez Encinas
Publikováno v:
Late breaking abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::11692ba5ba46ca9f620b6b7dfb125171
https://doi.org/10.1136/ejhpharm-2023-eahp.394
https://doi.org/10.1136/ejhpharm-2023-eahp.394
Autor:
A Sanjuán Belda, PA López Broseta, I Sacanella Angles, H Suñer Barriga, S Jornet Montaña, M Martin Marqués, E Esteve Pitarch, JDLMBoada Hernandez, A Lloret Llorca, I Plo Seco, L Canadell Vilarrasa
Publikováno v:
Section 5: Patient safety and quality assurance.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::110508f0b0799ddbf87d5c61a9d00519
https://doi.org/10.1136/ejhpharm-2022-eahp.317
https://doi.org/10.1136/ejhpharm-2022-eahp.317
Autor:
L Carrasco Piernavieja, JJ Martínez Simón, S Sanz Márquez, M. D. C. Morales Catalan, M Pérez Encinas, I Plo Seco, S. Lorenzo Martínez, I. Oterino Moreira, E Zhan Zhou, P. Roldan Navarro, I. Salvador Llana
Publikováno v:
Section 5: Patient safety and quality assurance.
Background and importance In response to the COVID-19 pandemic, scientific societies and regulatory agencies quickly reviewed any available evidence to fill the therapeutic gap In this context, many drugs were used with an uncertain benefit- risk pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8654778397af3928fee483dc11a27a50
https://doi.org/10.1136/ejhpharm-2021-eahpconf.340
https://doi.org/10.1136/ejhpharm-2021-eahpconf.340
Autor:
S Álvarez Atienza, M Domínguez Bachiller, Javier, Esther, JJ Martínez Simón, M Renilla Sánchez, M Pérez Encinas, S Sanz Márquez, I Plo Seco
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background and importance Prescription in the emergency department (ED) is compromised by multiple causes which could lead to a higher risk of medication errors. Aim and objectives To compare and analyse pharmaceutical interventions (PIs) performed i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1c9a2eb3d167b5a7c73b515da18a8a01
https://doi.org/10.1136/ejhpharm-2020-eahpconf.271
https://doi.org/10.1136/ejhpharm-2020-eahpconf.271
Autor:
J Valverde Canovas, E Pérez Fernández, I Plo Seco, S Sanz Márquez, L Moreno Nuñez, E Zhan Zhou, M Pérez Encinas, Francisco
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background and importance Inappropriate prescription of antimicrobials has been shown to be a cause of microbial resistance. Antibiotics are some of the most prescribed drugs in the emergency department (ED). An educational intervention by a multidis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ca17c9b191139eee6a6e6ea4bd6a9db3
https://doi.org/10.1136/ejhpharm-2020-eahpconf.155
https://doi.org/10.1136/ejhpharm-2020-eahpconf.155
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background Allergic asthma is the most prevalent phenotype of severe asthma in which treatment with omalizumab has been proven to be beneficial. Purpose Analyse the effectiveness, efficiency and safety of omalizumab in patients with uncontrolled mode
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::851510a67a89aad0819cbd80448e7115
https://doi.org/10.1136/ejhpharm-2019-eahpconf.331
https://doi.org/10.1136/ejhpharm-2019-eahpconf.331
Autor:
P Sanmartin Fenollera, I Plo Seco, JJ Martínez Simón, P. Roldan Navarro, M Pérez Encinas, I. Oterino Moreira, P Toro Chico
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background Nab-paclitaxel was approved for the treatment of metastatic adenocarcinoma of pancreas (mPAC), as a first treatment in combination with gemcitabine Purpose To evaluate the effectiveness and safety of nab-paclitaxel in patients with mPAC in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::41137254dd9bb8f545eed01f5fe9dc39
https://doi.org/10.1136/ejhpharm-2019-eahpconf.275
https://doi.org/10.1136/ejhpharm-2019-eahpconf.275
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.